Chair, Department of Chemical Physiology, The Scripps Research Institute; Co-director, Center for Physiological Proteomics, The Scripps Research Institute
Vice President for Research at UT Health Science Center at San Antonio
CEO of Foundry
Partner, Third Rock Ventures
This one-day symposium will cover the new discoveries, challenges, and lessons in the development of RNAI screening technologies. The agenda features speakers from Alnylam Pharmaceuticals, the Massachusetts Institute of Technology, Novartis Institutes for Biomedical Research, and New York University.